Alterations in the aqueous humor proteome in patients with a glaucoma shunt device

Molecular Vision

Volumn 17, Issue , 2011, Pages 1891-1900

  Anshu, Arundhati ^a,b   Price, Marianne O ^b   Richardson, Matthew R ^c   Segu, Zaneer M ^d   Lai, Xianyin ^c   Yoder, Mervin C ^c   Price, Francis W ^a  

^a PRICE VISION GROUP   (United States)

^b Lautert)   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFAMIN; ALBUMIN; ANGIOTENSINOGEN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; BETA 2 MICROGLOBULIN; COMPLEMENT COMPONENT C4A; DICKKOPF 3 PROTEIN; FIBRONECTIN; FIBRONECTIN 1; GELSOLIN; GLYCOPROTEIN; PATTERN RECOGNITION RECEPTOR; PIGMENT EPITHELIUM DERIVED FACTOR; PLASMINOGEN; PROTHROMBIN; RIG LIKE 7-1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; AQUEOUS HUMOR; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLAUCOMA; GLAUCOMA DRAINAGE IMPLANT; HUMAN; IMMUNITY; INFLAMMATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEOMICS;

ADULT; AGED; AQUEOUS HUMOR; BLOOD PROTEINS; BLOOD-AQUEOUS BARRIER; CASE-CONTROL STUDIES; CATARACT; CATARACT EXTRACTION; CHROMATOGRAPHY, LIQUID; FEMALE; GLAUCOMA; GLAUCOMA DRAINAGE IMPLANTS; HUMANS; LENS, CRYSTALLINE; MALE; MIDDLE AGED; PROTEIN TRANSPORT; PROTEOME; TANDEM MASS SPECTROMETRY;

EID: 79960734763     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Wilson SE, Kaufman HE. Graft failure after penetrating keratoplasty. Surv Ophthalmol 1990; 34:325-56.
2. Thompson RW Jr, Price MO, Bowers PJ, Price FW Jr. Longterm graft survival after penetrating keratoplasty. Ophthalmology 2003; 110:1396-402.
3. Ayyala RS. Penetrating keratoplasty and glaucoma. Surv Ophthalmol 2000; 45:91-105.
4. Seitz B, Langenbucher A, Nguyen NX, Kuchle M, Naumann GO. Long-term follow-up of intraocular pressure after penetrating keratoplasty for keratoconus and Fuchs' dystrophy: comparison of mechanical and Excimer laser trephination. Cornea 2002; 21:368-373.
5. Greenlee EC, Kwon YH. Graft failure: III. Glaucoma escalation after penetrating keratoplasty. Int Ophthalmol 2008; 28:191-207.
6. Williams KA, Lowe M, Bartlett C, Kelly TL, Coster DJ. Risk factors for human corneal graft failure within the Australian corneal graft registry. Transplantation 2008; 86:1720-4.
7. Sugar A, Tanner JP, Dontchev M, Tennant B, Schultze RL, Dunn SP, Lindquist TD, Gal RL, Beck RW, Kollman C, Mannis MJ, Holland EJ. Recipient risk factors for graft failure in the cornea donor study. Ophthalmology 2009; 116:1023-8.
8. Kwon YH, Taylor JM, Hong S, Honkanen RA, Zimmerman MB, Alward WL, Sutphin JE. Long-term results of eyes with penetrating keratoplasty and glaucoma drainage tube implant. Ophthalmology 2001; 108:272-8.
9. Alvarenga LS, Mannis MJ, Brandt JD, Lee WB, Schwab IR, Lim MC. The long-term results of keratoplasty in eyes with a glaucoma drainage device. Am J Ophthalmol 2004; 138:200-5.
10. Al-Torbak A. Graft survival and glaucoma outcome after simultaneous penetrating keratoplasty and ahmed glaucoma valve implant. Cornea 2003; 22:194-7.
11. Price MO, Fairchild KM, Price DA, Price FW Jr. Descemet's Stripping Endothelial Keratoplasty Five-Year Graft Survival and Endothelial Cell Loss. Ophthalmology 2011; 118:725-9.
12. Kim CS, Yim JH, Lee EK, Lee NH. Changes in corneal endothelial cell density and morphology after Ahmed glaucoma valve implantation during the first year of follow up. Clin Experiment Ophthalmol 2008; 36:142-7.
13. Kirkness CM. Penetrating keratoplasty, glaucoma and silicone drainage tubing. Dev Ophthalmol 1987; 14:161-5.
14. McDonnell PJ, Robin JB, Schanzlin DJ, Minckler D, Baerveldt G, Smith RE, Heuer D. Molteno implant for control of glaucoma in eyes after penetrating keratoplasty. Ophthalmology 1988; 95:364-9.
15. Topouzis F, Coleman AL, Choplin N, Bethlem MM, Hill R, Yu F, Panek WC, Wilson MR. Follow-up of the original cohort with the Ahmed glaucoma valve implant. Am J Ophthalmol 1999; 128:198-204.
16. Funding M, Vorum H, Honore B, Nexo E, Ehlers N. Proteomic analysis of aqueous humour from patients with acute corneal rejection. Acta Ophthalmol Scand 2005; 83:31-9.
17. Duan X, Lu Q, Xue P, Zhang H, Dong Z, Yang F, Wang N. Proteomic analysis of aqueous humor from patients with myopia. Mol Vis 2008; 14:370-7.
18. Richardson MR, Segu ZM, Price MO, Lai X, Witzmann FA, Mechref Y, Yoder MC, Price FW. Alterations in the aqueous humor proteome in patients with Fuchs endothelial corneal dystrophy. Mol Vis 2010; 16:2376-83.
19. Bramsen T, Stenbjerg S. Fibrinolytic factors in aqueous humour and serum from patients with Fuchs' dystrophy and patients with cataract. Acta Ophthalmol (Copenh) 1979; 57:470-6.
20. Wilson SE, Bourne WM, Maguire LJ, Rahhal FM, Ribaudo RK, Kreutzer DL, O'Rourke J. Aqueous humor composition in Fuchs' dystrophy. Invest Ophthalmol Vis Sci 1989; 30:449-453.
21. Bouhenni RA, Al Shahwan S, Morales J, Wakim BT, Chomyk AM, Alkuraya FS, Edward DP. Identification of differentially expressed proteins in the aqueous humor of primary congenital glaucoma. Exp Eye Res 2011; 92:67-75.
22. Izzotti A, Longobardi M, Cartiglia C, Sacca SC. Proteome alterations in primary open angle glaucoma aqueous humor. J Proteome Res 2010; 9:4831-8.
23. Grus FH, Joachim SC, Sandmann S, Thiel U, Bruns K, Lackner KJ, Pfeiffer N. Transthyretin and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma. Mol Vis 2008; 14:1437-1445.
24. Duan X, Xue P, Wang N, Dong Z, Lu Q, Yang F. Proteomic analysis of aqueous humor from patients with primary open angle glaucoma. Mol Vis 2010; 16:2839-2846.
25. Fuchshofer R, Tamm ER. Modulation of extracellular matrix turnover in the trabecular meshwork. Exp Eye Res 2009; 88:683-8.
26. Alvarado JA, Yeh RF, Franse-Carman L, Marcellino G, Brownstein MJ. Interactions between endothelia of the trabecular meshwork and of Schlemm's canal: a new insight into the regulation of aqueous outflow in the eye. Trans Am Ophthalmol Soc 2005; 103:148-162.
27. Richardson MR, Price MO, Price FW, Pardo JC, Grandin JC, You J, Wang M, Yoder MC. Proteomic analysis of human aqueous humor using multidimensional protein identification technology. Mol Vis 2009; 15:2740-2750.
28. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002; 74:5383-5392.
29. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003; 75:4646-4658.
30. Vesaluoma M, Mertaniemi P, Mannonen S, Lehto I, Uusitalo R, Sarna S, Tarkkanen A, Tervo T. Cellular and plasma fibronectin in the aqueous humour of primary open-angle glaucoma, exfoliative glaucoma and cataract patients. Eye (Lond) 1998; 12:886-890.
31. Ogata N, Matsuoka M, Imaizumi M, Arichi M, Matsumura M. Decrease of pigment epithelium-derived factor in aqueous humor with increasing age. Am J Ophthalmol 2004; 137:935-6.
32. Tezel G, Yang X, Luo C, Kain AD, Powell DW, Kuehn MH, Kaplan HJ. Oxidative stress and the regulation of complement activation in human glaucoma. Invest Ophthalmol Vis Sci 2010; 51:5071-5082.
33. O'Brien C, Butt Z, Ludlam C, Detkova P. Activation of the coagulation cascade in untreated primary open-angle glaucoma. Ophthalmology 1997; 104:725-729.
34. Cullinane AB, Leung PS, Ortego J, Coca-Prados M, Harvey BJ. Renin-angiotensin system expression and secretory function in cultured human ciliary body non-pigmented epithelium. Br J Ophthalmol 2002; 86:676-683.
35. Dan J, Belyea D, Gertner G, Leshem I, Lusky M, Miskin R. Plasminogen activator inhibitor-1 in the aqueous humor of patients with and without glaucoma. Arch Ophthalmol 2005; 123:220-224.
36. Kinasewitz GT, Yan SB, Basson B, Comp P, Russell JA, Cariou A, Um SL, Utterback B, Laterre PF, Dhainaut JF. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative microorganism. Crit Care 2004; 8:R82-90.ISRCTN74215569
37. Wilson SE, Schultz GS, Chegini N, Weng J, He YG. Epidermal growth factor, transforming growth factor alpha, transforming growth factor beta, acidic fibroblast growth factor, basic fibroblast growth factor, and interleukin-1 proteins in the cornea. Exp Eye Res 1994; 59:63-71.
38. Sekine-Okano M, Lucas R, Rungger D, De Kesel T, Grau GE, Leuenberger PM, Rungger-Brandle E. Expression and release of tumor necrosis factor-alpha by explants of mouse cornea. Invest Ophthalmol Vis Sci 1996; 37:1302-1310.
39. Heiser M, Hutter-Paier B, Jerkovic L, Pfragner R, Windisch M, Becker-Andre M, Dieplinger H. Vitamin E binding protein afamin protects neuronal cells in vitro. J Neural Transm Suppl 2002; (62):337-345.
40. Chauhan V, Ji L, Chauhan A. Anti-amyloidogenic, anti-oxidant and anti-apoptotic role of gelsolin in Alzheimer's disease. Biogerontology 2008; 9:381-389.
41. Paunio T, Kangas H, Kalkkinen N, Haltia M, Palo J, Peltonen L. Toward understanding the pathogenic mechanisms in gelsolin-related amyloidosis: in vitro expression reveals an abnormal gelsolin fragment. Hum Mol Genet 1994; 3:2223-2229.
42. Bucki R, Levental I, Kulakowska A, Janmey PA. Plasma gelsolin: function, prognostic value, and potential therapeutic use. Curr Protein Pept Sci 2008; 9:541-551.
43. Saccà SC, Pascotto A, Camicione P, Capris P, Izzotti A. Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch Ophthalmol 2005; 123:458-463.
44. Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res 2006; 25:490-513.
45. Ferreira SM, Lerner SF, Brunzini R, Evelson PA, Llesuy SF. Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol 2004; 137:62-69.
46. Zhang SX, Wang JJ, Gao G, Shao C, Mott R, Ma JX. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor. FASEB J 2006; 20:323-325.
47. Zhou X, Li F, Kong L, Chodosh J, Cao W. Anti-inflammatory effect of pigment epithelium-derived factor in DBA/2J mice. Mol Vis 2009; 15:438-450.
48. Taki-ta H, Yoneya S, Gehlbach PL, Duh EJ, Wei LL, Mori K. Retinal neuroprotection against ischemic injury mediated by intraocular gene transfer of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 2003; 44:4497-4504.
49. Jung IL, Kang HJ, Kim KC, Kim IG. Knockdown of the Dickkopf 3 gene induces apoptosis in a lung adenocarcinoma. Int J Mol Med 2010; 26:33-38.
50. Nakamura RE, Hunter DD, Yi H, Brunken WJ, Hackam AS. Identification of two novel activities of the Wnt signaling regulator Dickkopf 3 and characterization of its expression in the mouse retina. BMC Cell Biol 2007; 8:52.
51. Burger D, Dayer JM. High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation? Autoimmun Rev 2002; 1:111-117.
52. Opitz B, Eitel J, Meixenberger K, Suttorp N. Role of Toll-like receptors, NOD-like receptors and RIG-I-like receptors in endothelial cells and systemic infections. Thromb Haemost 2009; 102:1103-1109.
53. Erez E, Aravot D, Erman A, Sharoni E, Raanani E, Abramov D, Dijk DV, Sahar G, Vidne BA. Beta-2 microglobulin in heart transplanted patients. Transplant Proc 1997; 29:2706-2707.
54. Roxe DM, Siddiqui F, Santhanam S, del Greco F, Wolf J. Rationale and application of beta-2-microglobulin measurements to detect acute transplant rejection. Nephron 1981; 27:260-264.